Print

Print


+++++++++++++++++++++++++++++++++++++++++++++++++
Posted Fri, 15 Jan 2016 16:37:01
This message was forwarded through MEDSOCNEWS.
If you wish to make an announcement or publicise
an event then please send the text to:
[log in to unmask]
You can follow us on twitter @MedSocNews
+++++++++++++++++++++++++++++++++++++++++++++++++

Dear colleagues,

Papers are now invited for the following panel:

P25: Biomedicine, entrepreneurship and future ecologies of healthcare

*ASA 2016, University of Durham, 4-7 July 2016

*Convenors: Margaret Sleeboom-Faulkner and Marina Marouda (University of Sussex)

Short outline:

This panel will consider the increasing commodification of biomedical interventions in medical care and its implications for the future of human health. It examines the entrepreneurial practices that shape biomedical research and innovation and, as a consequence, the future of healthcare.

Panel Abstract:
Biomedical technologies have become a major engine of change in global health care, constituting a prime means by which governments aspire to ameliorate disease and disability everywhere. Business considerations and commercial practices are driving developments in biomedicine, with both public and private health providers engaging in bioentrepreneurial undertakings. The emergence of innovative bioindustries have captured the interest of social scientists but despite the abundance of reflections on bioeconomy in academic discourse, very little is known about the actual ways through which biomedical markets are created. The panel considers the entrepreneurial engagements through which biomedical innovation is created, and asks how such engagements are changing the institutional nature of medical practice and the challenges this poses for the future of human health. What does the growing commercialisation of biomedical knowledge and practice mean for health care provision?
The panel invites contributions that explore in detail entrepreneurial engagements in biomedicine tracing the ways in which biomedical ventures are constituted. What are the legal and regulatory frameworks, scientific environments and institutional exchanges through which biomedical knowledge is turned into profitable ventures? We have a preference for ethnographic cases that chart complex institutional settings, dispersed networks, and collaborative flows as instrumental in the makings of successful biotech enterprises.
The panel will also critically reflect on the role of anthropological knowledge in shaping developments in human health, by locating the production of this knowledge within ongoing processes of commoditisation, and examining the positions anthropologists are called to occupy with respect to bioentrepreneurial projects.
The deadline for paper proposals is 15 February 2016.

To propose a paper, please follow this link:
http://www.nomadit.co.uk/asa/asa2016/panels.php5?PanelID=4304

For informal inquiries, please contact panel convenors Margaret Sleeboom-Faulkner ([log in to unmask]) and Marina Marouda ([log in to unmask]).



**********************************************************************
1. For general enquires or problems with the list or to CHANGE YOUR EMAIL ADDRESS send a message to:
[log in to unmask]
2. To suspend yourself from the list, whilst on leave, for example,
send an email to [log in to unmask] with the following message:
set medsocnews nomail
3. To resume email from the list, send the following message:
set medsocnews mail
4. To leave MedSocNews, send an email to [log in to unmask] with the message (leave the subject line blank and do not include a signature):
leave medsocnews
5. To join or subscribe to MedSocNews, send an email to [log in to unmask] with the message (leave the subject line blank and do not include a signature):
SUBSCRIBE medsocnews firstname lastname
6. Further information about the medsocnews discussion list (including
list archive and how to subscribe to or leave the list) can be found
at the list web site:
http://www.jiscmail.ac.uk/lists/medsocnews.html
**********************************************************************